Skip to main content

olmesartan medoxomil

Generic: OLMESARTAN MEDOXOMIL·Brand: Azor, BENICAR, Benicar, Benicar HCT, OLMESARTAN MEDOXOMIL, Tribenzor

olmesartan medoxomil: 1 clinical trial tracked.

olmesartan medoxomil evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about olmesartan medoxomil, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (1)

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication

NCT05103332Registry updated 2025-11-03·Phase 2·ALNY
Completed

Primary endpoint: Indapamide: Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPM - Censored Data

InterventionalRandomizedquadruple663 enrolledStarted 2021-11Completion 2024-0950 sites · United StatesAlnylam Pharmaceuticals